NO20000752L - Metode for forhindring eller behandling av østrogen-avhengige sykdommer og forstyrrelser - Google Patents
Metode for forhindring eller behandling av østrogen-avhengige sykdommer og forstyrrelserInfo
- Publication number
- NO20000752L NO20000752L NO20000752A NO20000752A NO20000752L NO 20000752 L NO20000752 L NO 20000752L NO 20000752 A NO20000752 A NO 20000752A NO 20000752 A NO20000752 A NO 20000752A NO 20000752 L NO20000752 L NO 20000752L
- Authority
- NO
- Norway
- Prior art keywords
- disorders
- preventing
- dependent diseases
- treating estrogen
- estrogen
- Prior art date
Links
- 230000001419 dependent effect Effects 0.000 title abstract 3
- 229940011871 estrogen Drugs 0.000 title abstract 3
- 239000000262 estrogen Substances 0.000 title abstract 3
- 208000037765 diseases and disorders Diseases 0.000 title abstract 2
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 229940046836 anti-estrogen Drugs 0.000 abstract 1
- 230000001833 anti-estrogenic effect Effects 0.000 abstract 1
- 239000000328 estrogen antagonist Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5588197P | 1997-08-15 | 1997-08-15 | |
PCT/US1998/016864 WO1999008682A1 (en) | 1997-08-15 | 1998-08-14 | A method of preventing or treating estrogen-dependent diseases and disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20000752L true NO20000752L (no) | 2000-02-15 |
NO20000752D0 NO20000752D0 (no) | 2000-02-15 |
Family
ID=22000784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20000752A NO20000752D0 (no) | 1997-08-15 | 2000-02-15 | Metode for forhindring eller behandling av østrogen-avhengige sykdommer og forstyrrelser |
Country Status (21)
Country | Link |
---|---|
US (1) | US7307102B2 (no) |
EP (1) | EP1019057B1 (no) |
JP (1) | JP2001515038A (no) |
KR (1) | KR20010022956A (no) |
CN (1) | CN1275911A (no) |
AT (1) | ATE411016T1 (no) |
AU (1) | AU757206B2 (no) |
BR (1) | BR9811946A (no) |
CA (1) | CA2301032C (no) |
CZ (1) | CZ300929B6 (no) |
DE (1) | DE69840126D1 (no) |
EE (1) | EE200000077A (no) |
ES (1) | ES2312189T3 (no) |
HU (1) | HUP0002852A3 (no) |
IL (1) | IL134445A0 (no) |
NO (1) | NO20000752D0 (no) |
NZ (1) | NZ502738A (no) |
PL (1) | PL338555A1 (no) |
RU (1) | RU2214236C2 (no) |
UA (1) | UA70925C2 (no) |
WO (1) | WO1999008682A1 (no) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6413533B1 (en) * | 1998-05-07 | 2002-07-02 | The University Of Tennessee Research Corporation | Method for chemoprevention of prostate cancer |
AU4676999A (en) * | 1998-06-12 | 1999-12-30 | Ligand Pharmaceuticals, Inc. | Treatment of anti-estrogen resistant breast cancer using rxr modulators |
GB9824207D0 (en) * | 1998-11-04 | 1998-12-30 | Zeneca Ltd | Neurological disorders |
ATE447947T1 (de) * | 1999-07-06 | 2009-11-15 | Endorech Inc | Pharmazeutische zubereitungen zur behandlung von insulinresitenz |
CO5271709A1 (es) | 2000-01-12 | 2003-04-30 | Pfizer Prod Inc | Composiciones y procedimientos para el y tratamiento de afecciones que responden a estrogenos |
US6417394B2 (en) * | 2000-04-05 | 2002-07-09 | Bristol Myers Squibb Pharma Company | Specific salt forms of triphenylethylene derivatives as selective estrogen receptor modulators |
US6528681B2 (en) * | 2000-04-05 | 2003-03-04 | Bristol-Meyers Squibb Pharma Company | Halogenated triphenylethylene derivatives as selective estrogen receptor modulators |
CA2418003C (en) * | 2000-07-05 | 2012-12-04 | Andrew J. E. Seely | Method and apparatus for multiple patient parameter variability analysis and display |
EP1365763B1 (en) * | 2001-02-15 | 2008-11-26 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitor combinations with antiestrogen agents |
US20020164581A1 (en) * | 2001-03-12 | 2002-11-07 | Chawnshang Chang | Methods for identifying compounds that do not attenuate the protective effects of estrogen |
AU2002323098A1 (en) | 2001-08-11 | 2003-03-03 | Bristol-Myers Squibb Pharma Company | Selective estrogen receptor modulators |
SG140607A1 (en) | 2004-06-23 | 2008-03-28 | Sirion Therapeutics Inc | Methods and compositions for treating ophthalmic conditions with retinyl derivatives |
KR20070091283A (ko) | 2004-11-04 | 2007-09-10 | 시리온 테라퓨틱스, 인크. | 레티놀-레티놀 결합단백질(rbp)-트랜스타이레틴(ttr) 복합체 형성의조절 인자 |
KR100890410B1 (ko) * | 2004-12-08 | 2009-03-26 | 시리온 테라퓨틱스, 인크. | 레티놀-관련 질환의 치료 방법, 검정법 및 치료용 조성물 |
US20060264413A1 (en) * | 2005-04-18 | 2006-11-23 | Sri International | Method and composition for inhibiting cell proliferation and angiogenesis |
UA81382C2 (en) * | 2005-07-11 | 2007-12-25 | Composition for treating retinol-related diseases by modulation of retinol binding | |
EP2206053A4 (en) * | 2007-10-03 | 2012-11-21 | Ottawa Hospital Res Inst | METHOD AND DEVICE FOR MONITORING THE VARIABILITY OF PHYSIOLOGICAL PARAMETERS OVER TIME FOR ONE OR MORE ORGANS |
WO2009151683A2 (en) | 2008-03-12 | 2009-12-17 | Link Medicine Corporation | Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications |
CN102369202A (zh) | 2008-11-13 | 2012-03-07 | 链接医药公司 | 氮杂喹啉酮衍生物及其应用 |
EA022551B1 (ru) | 2010-06-10 | 2016-01-29 | Серагон Фармасьютикалс, Инк. | Модуляторы рецепторов эстрогена и их применение |
WO2011159769A2 (en) | 2010-06-17 | 2011-12-22 | Aragon Pharmaceuticals, Inc. | Indane estrogen receptor modulators and uses thereof |
GB2483736B (en) | 2010-09-16 | 2012-08-29 | Aragon Pharmaceuticals Inc | Estrogen receptor modulators and uses thereof |
CA2857057A1 (en) | 2011-12-14 | 2013-06-20 | Seragon Pharmaceuticals, Inc. | Fluorinated estrogen receptor modulators and uses thereof |
CN102584687A (zh) * | 2011-12-30 | 2012-07-18 | 北京赛林泰医药技术有限公司 | 作为选择性雌激素受体调节剂的乙烯衍生物 |
CN102532073A (zh) * | 2011-12-30 | 2012-07-04 | 北京赛林泰医药技术有限公司 | 作为选择性雌激素受体调节剂的乙烯衍生物 |
US9499538B2 (en) | 2012-03-20 | 2016-11-22 | Seragon Pharmaceuticals, Inc. | Estrogen receptor modulators and uses thereof |
CA3008020C (en) * | 2015-12-09 | 2024-02-20 | The Board Of Trustees Of The University Of Illinois | Benzothiophene-based selective estrogen receptor downregulators |
CA3071270A1 (en) * | 2017-07-28 | 2019-01-31 | Recurium Ip Holdings, Llc | Acrylic acid analogs |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE637389A (no) | 1962-09-13 | |||
GB1029221A (en) | 1963-09-02 | 1966-05-11 | Ici Ltd | Triarylalkane derivatives |
GB1079747A (en) | 1965-07-07 | 1967-08-16 | Ici Ltd | Alkene derivatives |
US3637856A (en) | 1965-07-12 | 1972-01-25 | Ici Ltd | Trans-1-p-(dialkylaminoalkyl) phenyl-1 2-diphenyl-alk-1-enes and salts thereof |
GB1128379A (en) | 1966-06-20 | 1968-09-25 | Ici Ltd | Novel alkene derivatives, process for the preparation thereof and compositions containing the same |
GB1560274A (en) | 1977-02-28 | 1980-02-06 | Ici Ltd | Phenylbut 1-ene derivatives having antiostrogenicactivity |
EP0002097B1 (en) | 1977-08-22 | 1981-08-05 | Imperial Chemical Industries Plc | Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them |
US4206234A (en) | 1977-08-22 | 1980-06-03 | Imperial Chemical Industries Limited | Triphenylbut-1-ene derivatives and pharmaceutical compositions and uses thereof |
EP0019377B1 (en) | 1979-05-15 | 1982-08-04 | Imperial Chemical Industries Plc | 1-hydrocarbyloxyphenyl-1,2-diphenylalkene derivatives, their manufacture and a pharmaceutical composition containing them |
HU178253B (en) | 1979-08-15 | 1982-04-28 | Gyogyszerkutato Intezet | Process for preparing 1,1,2-triphenyl-propane and -propane derivatives |
DE3046719C2 (de) | 1980-12-11 | 1983-02-17 | Klinge Pharma GmbH, 8000 München | 1,1,2-Triphenyl-but-1-en-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel |
FI77839C (fi) | 1982-05-27 | 1989-05-10 | Farmos Oy | Foerfarande foer framstaellning av nya terapeutiskt effektiva trifenylalkan- och alkenderivat. |
US5491173A (en) * | 1982-06-25 | 1996-02-13 | Orion-Yhtyma Oy | Tri-phenyl alkene derivatives and their preparation and use |
CA1229604A (en) | 1984-02-14 | 1987-11-24 | Lorne J. Brandes | Aminoalkyl ethers of phenols as antiproliferative anticancer agents |
US4760053A (en) | 1984-08-02 | 1988-07-26 | Fernand Labrie | Combination therapy for selected sex steroid dependent cancers |
US4729999A (en) | 1984-10-12 | 1988-03-08 | Bcm Technologies | Antiestrogen therapy for symptoms of estrogen deficiency |
GB8604528D0 (en) | 1986-02-24 | 1986-04-03 | Ici Plc | Therapeutic agents |
US4859695A (en) | 1986-06-10 | 1989-08-22 | Merck & Co., Inc. | Antiestrogen agents having anabolic activity in animals |
CA1289570C (en) | 1986-06-16 | 1991-09-24 | Tetsuji Asao | 1,1,2-triaryl-1-alkene derivatives |
DE3736682A1 (de) | 1987-10-29 | 1989-05-11 | Klinge Co Chem Pharm Fab | Verfahren zur herstellung von trans-1,1,2-triphenyl-but-1-en-derivaten |
US5393785A (en) | 1988-10-31 | 1995-02-28 | Endorecherche, Inc. | Therapeutic antiestrogens |
US5119827A (en) | 1990-09-05 | 1992-06-09 | Board Of Regents, The University Of Texas System | Mechanisms of antiestrogen resistance in breast cancer |
US5189212A (en) * | 1990-09-07 | 1993-02-23 | University Of Georgia Research Foundation, Inc. | Triarylethylene carboxylic acids with estrogenic activity |
WO1992006068A1 (en) | 1990-10-01 | 1992-04-16 | Board Of Regents, The University Of Texas System | High affinity tamoxifen derivatives and uses thereof |
CA2109426A1 (en) | 1991-04-30 | 1992-10-31 | Hiroyuki Kouji | Triphenylethylene derivative and pharmaceutical drug containing the same |
AU672234B2 (en) | 1992-09-15 | 1996-09-26 | Merrell Dow Pharmaceuticals Inc. | Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors |
DE4311870C2 (de) * | 1993-04-10 | 1998-07-30 | Altramed Holdings Ltd | Verwendung eines Anti-Östrigens zur Therapie und Prophylaxe von Demenz-Erkrankungen |
US5681835A (en) * | 1994-04-25 | 1997-10-28 | Glaxo Wellcome Inc. | Non-steroidal ligands for the estrogen receptor |
US5455275A (en) * | 1994-05-11 | 1995-10-03 | Eli Lilly And Company | Methods for inhibiting endometriosis and uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives |
-
1998
- 1998-08-14 DE DE69840126T patent/DE69840126D1/de not_active Expired - Fee Related
- 1998-08-14 UA UA2000020847A patent/UA70925C2/uk unknown
- 1998-08-14 HU HU0002852A patent/HUP0002852A3/hu unknown
- 1998-08-14 EE EEP200000077A patent/EE200000077A/xx unknown
- 1998-08-14 ES ES98940886T patent/ES2312189T3/es not_active Expired - Lifetime
- 1998-08-14 AT AT98940886T patent/ATE411016T1/de not_active IP Right Cessation
- 1998-08-14 NZ NZ502738A patent/NZ502738A/en unknown
- 1998-08-14 RU RU2000106448/14A patent/RU2214236C2/ru not_active IP Right Cessation
- 1998-08-14 CN CN98810214A patent/CN1275911A/zh active Pending
- 1998-08-14 JP JP2000509421A patent/JP2001515038A/ja active Pending
- 1998-08-14 EP EP98940886A patent/EP1019057B1/en not_active Expired - Lifetime
- 1998-08-14 CZ CZ20000531A patent/CZ300929B6/cs not_active IP Right Cessation
- 1998-08-14 CA CA002301032A patent/CA2301032C/en not_active Expired - Fee Related
- 1998-08-14 PL PL98338555A patent/PL338555A1/xx unknown
- 1998-08-14 WO PCT/US1998/016864 patent/WO1999008682A1/en not_active Application Discontinuation
- 1998-08-14 IL IL13444598A patent/IL134445A0/xx not_active IP Right Cessation
- 1998-08-14 BR BR9811946-0A patent/BR9811946A/pt not_active IP Right Cessation
- 1998-08-14 AU AU89063/98A patent/AU757206B2/en not_active Ceased
- 1998-08-14 KR KR1020007001564A patent/KR20010022956A/ko active Search and Examination
-
2000
- 2000-02-15 NO NO20000752A patent/NO20000752D0/no not_active Application Discontinuation
-
2003
- 2003-03-18 US US10/390,032 patent/US7307102B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69840126D1 (de) | 2008-11-27 |
AU757206B2 (en) | 2003-02-06 |
RU2214236C2 (ru) | 2003-10-20 |
ATE411016T1 (de) | 2008-10-15 |
CA2301032A1 (en) | 1999-02-25 |
KR20010022956A (ko) | 2001-03-26 |
EP1019057A4 (en) | 2006-06-14 |
PL338555A1 (en) | 2000-11-06 |
US20030232795A1 (en) | 2003-12-18 |
HUP0002852A2 (hu) | 2001-10-28 |
AU8906398A (en) | 1999-03-08 |
CN1275911A (zh) | 2000-12-06 |
CZ300929B6 (cs) | 2009-09-16 |
JP2001515038A (ja) | 2001-09-18 |
BR9811946A (pt) | 2000-08-22 |
NZ502738A (en) | 2002-06-28 |
HUP0002852A3 (en) | 2001-11-28 |
NO20000752D0 (no) | 2000-02-15 |
US7307102B2 (en) | 2007-12-11 |
CZ2000531A3 (en) | 2001-05-16 |
UA70925C2 (uk) | 2004-11-15 |
CA2301032C (en) | 2009-01-13 |
EP1019057B1 (en) | 2008-10-15 |
ES2312189T3 (es) | 2009-02-16 |
WO1999008682A1 (en) | 1999-02-25 |
IL134445A0 (en) | 2001-04-30 |
EE200000077A (et) | 2000-12-15 |
EP1019057A1 (en) | 2000-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20000752L (no) | Metode for forhindring eller behandling av østrogen-avhengige sykdommer og forstyrrelser | |
DE69708100D1 (de) | Konjugate von cis-docosahexaensäure und paclitaxel | |
FI965269A0 (fi) | Menetelmä syövän etäispesäkkeen ehkäisemiseksi modifioidun citrus pektiinin avulla | |
ATE425749T1 (de) | Behandlung von mit her-2/neu-uberexprimierung einhergehendem krebs | |
DE69826695D1 (de) | Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen | |
CY1109525T1 (el) | ΑΝΘΡΩΠΟΠΟΙΗΜΕΝΑ ΑΝΤΙΣΩΜΑΤΑ ΑΝΤΙ-ErbB2 ΚΑΙ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ ΜΕ ΑΝΤΙΣΩΜΑΤΑ ΑΝΤΙ-ErbB2 | |
GB9815177D0 (en) | Treatment of skin disorders | |
ATE258796T1 (de) | Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen | |
ATE239509T1 (de) | Konjugate zur behandlung von prostatakrebs | |
PT1109571E (pt) | Metodos de tratamento da hipertensao e composicoes para utilizacao nesses metodos | |
DE69927688D1 (de) | Antivirales Mittel in Kombination mit Strahlentherapie zur Verwendung in der Behandlung von Krebs | |
ATE261724T1 (de) | Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen | |
MD1569G2 (ro) | Metodă de tratament al cancerului mamar în perioada preoperatorie | |
DE69835828D1 (de) | Muc-1 derivate und deren verwendung zur behandlung von krebsassoziierter muc-1 mucin induzierter immunosuppression | |
EP1143996A4 (en) | Method of treating chronic cardiac disease | |
DE60212415D1 (de) | Die verwendung von einer 4-pyridylmethylphtalazine enthaltenden kombination zur behandlung von tumoren | |
GB9723824D0 (en) | Cytostatic agents | |
UA34375A (uk) | Спосіб лікування рака молочної залози | |
PT1133297E (pt) | Nova aplicacao terapeutica da 1,6-dimetil-8beta-hidroximetil-10alfa-metoxiergolina | |
ATE249229T1 (de) | Verwendung von putamen ovi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |